Research & Clinical Trials
Use of Belatacept during Post Depletional Repopulation to Facilitate Tolerance in Renal Allograft Recipients” (BMS IM 103-036) - Enrolling
Principal Investigator: Allan D. Kirk, MD, PhD
Study Coordinator: Sue Mead, RN
Kidney Transplantation in Patients with Sickle Cell Disease - Enrolling
Principal Investigator: Nicole Turgeon, MD
Study Coordinator: Rivka Elbein, RN
Belatacept Compassionate Use in Renal Transplant (IM103-056) - Enrolling
Principal Investigator: Allan D. Kirk, MD, PhD
Study Coordinator: Elizabeth Ferry, RN
Bariatric Surgery in Obese End Stage Renal Disease Patients - Enrolling
Principal Investigator: Nicole Turgeon, MD
Study Coordinator: Terri Eubanks, CRC
Immune Monitoring and Assay Development in Organ Transplant Recipients - Enrolling
Principal Investigator: Allan D. Kirk, MD, PhD
Study Coordinator: Shine Thomas, CRC
Open-Label, Randomized, Controlled, Multiple-Dose Study of Efficacy and Safety of LEA29Y as Part of a Quadruple Drug Regimen in First Renal Transplant Recipient (IM103-100) - Closed to Enrollment
Principal Investigator: Christian Larsen, MD, DPhil
Study Coordinator: Beth Begley, RN
Identification and Mechanistic Investigations of Tolerant Kidney Transplant Patients (ITN507st) - Enrolling
Principal Investigator: Kenneth Newell, MD, PhD
Study Coordinator: Terri Eubanks, CRC
Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial- Extended Criteria Donors (BENEFIT-EXT, IM103-027) - Closed to Enrollment
Principal Investigator: Thomas Pearson, MD, DPhil
Study Coordinator: Elizabeth Ferry, RN
Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial (BENEFIT, IM103-008) - Closed to Enrollment
Principal Investigator: Thomas Pearson, MD, DPhil
Study Coordinator: Elizabeth Ferry
Solid Organ Transplant in HIV: Multi-Site Study - Closed to Enrollment
Principal Investigator: Thomas Pearson, MD, DPhil
Study Coordinator: Sue Mead, RN
Characterization of Impact of Chronic Immunosuppressive Regimens on Protective Immunity Over Time in Renal Transplant Recipients - Closed to Enrollment
Principal Investigator: Christian Larsen, MD, DPhil; Aneesh Mehta, MD
Study Coordinator: Rivka Elbein, RN
A Prospective Comparison the Magnitude and Character of the Immune Response to Influenza Vaccine in Defined Transplant Populations and Healthy Aged-Matched Volunteers - Closed to Enrollment
Principal Investigator: Christian Larsen, MD, PhD; Aneesh Mehta, MD
Study Coordinator: Beth Begley, RN
Noninvasive Monitoring to Predict Outcome in de novo Kidney Transplant Recipients (CTOT- 01) - Closed to Enrollment
Principal Investigator: Kenneth Newell, MD, PhD
Study Coordinator: Rivka Elbein, RN
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation, Version 4.0, Part B - Enrolling
Principal Investigator: Paul Tso, MD
Study Coordinator: Rivka Elbein, RN
Optimization of Belatacept Usage as a Means of Avoiding CNI and steroids in Renal Transplantation (CTOT-10) - IRB approval pending, not yet enrolling
Principal Investigator: Ken Newell, MD
Study Coordinator: Terri Eubanks, CRC
An Observational Study to Assess the Prevalence of a Tolerance Signature in Renal Transplant Recipients (ITN524st) - IRB approval pending, not yet enrolling
Principal Investigator: Ken Newell, MD
Study Coordinator: Terri Eubanks, CRC
Re-Trasplant in BK Virus Nephropathy: A Multi-center Experience - Retrospective Review
Investigator: Sudha Tata, MD
Coordinator: Beth Begley, RN
Cytomegalovirus and Renal Allograft Rejection - Retrospective Review
Investigator: Alan D. Kirk, MD, PhD
Coordinator: Madhu Subramanian, Beth Begley, RN
